A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+tumor cells-Reference-Cited by-同舟云学术

A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+tumor cells

Published:2014-03-26 Issue:3 Volume:6 Page:727-738
ISSN:1942-0870
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Reusch Uwe,Burkhardt Carmen,Fucek Ivica,Le Gall Fabrice,Le Gall Mikaelle,Hoffmann Karin,Knackmuss Stefan HJ,Kiprijanov Sergej,Little Melvyn,Zhukovsky Eugene A

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.28591

Reference34 articles.

1. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity

2. Biology and clinical relevance of human natural killer cells

3. The biology of human natural killer-cell subsets

4. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

5. Immunotherapeutic perspective for bispecific antibodies

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide;Antibodies;2024-09-10

2. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B;Antiviral Research;2024-09

3. Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers;mAbs;2024-07-24

4. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

5. Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective;Biomarker Research;2024-07-17